CHFS News and Press, Nuwellis

EDEN PRAIRIE, Minn., May 17, 2021 (GLOBE NEWSWIRE) -- Data supporting the effectiveness of Aquadex FlexFlow ® system in the treatment of acutely decompensated heart failure (ADHF) patients was presented May 16 th at the 2021 American College of Cardiology conference (ACC). ...

EDEN PRAIRIE, Minn., May 13, 2021 (GLOBE NEWSWIRE) -- Reaffirming its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., today announced that its...

EDEN PRAIRIE, Minn., May 11, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (previously CHF Solutions, Inc.) announced today its results for the first quarter ended March 31, 2021, which included the following highlights: Completed corporate rebranding from CHF Solutions, In...

EDEN PRAIRIE, Minn., April 29, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), formally CHF Solutions, announces today that its first quarter 2021 financial results will be released on Tuesday, May 11, 2021. The company will host a conference call and webcast at 9:00 AM ET,...

EDEN PRAIRIE, Minn., April 27, 2021 (GLOBE NEWSWIRE) -- Company names are reflective of the services provided to its customers, and CHF Solutions – a leader and pioneer in the heart failure space – has evolved to serve more than just the chronic heart failure community. The co...

EDEN PRAIRIE, Minn., April 23, 2021 (GLOBE NEWSWIRE) -- Improving access to life-saving fluid management therapies is a commitment CHF Solutions (Nasdaq: CHFS) stands by. The company today announced Aquadex SmartFlow ® is now available at two new pediatric hospitals in Texas. CHF S...

Shares of CHF Solutions Inc. (NASDAQ:CHFS) traded today at $5.15, breaking its 52-week low. Approximately 1.6 million shares have changed hands today, as compared to an average 30-day volume of 847,000 shares. There is potential upside of 20.9% for shares of CHF Solutions Inc. based on a...

CHF Solutions (CHFS) announces that Joe DiMaggio Children’s Hospital in Hollywood, Florida has enrolled the first patient in the Ultrafiltration Therapy Registry Using Aquadex (ULTRA-Peds Registry). ULTRA-Peds will collect real-world evidence on the safety, performance and utilization ...

EDEN PRAIRIE, Minn., April 20, 2021 (GLOBE NEWSWIRE) -- More pediatric clinical evidence is essential in understanding the real-world benefits of medical devices in children. CHF Solutions is committed to expanding pediatric-specific data, and today announced Joe DiMaggio Children’s ...

CHF Solutions Inc. (NASDAQ:CHFS) traded at a new 52-week low today of $5.14. Approximately 1.6 million shares have changed hands today, as compared to an average 30-day volume of 847,000 shares. CHF Solutions Inc is a medical device company. It focuses on commercializing the Aquadex Flex...